Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia.
about
The developmental transcriptome of the human brain: implications for neurodevelopmental disordersRNA Sequencing in SchizophreniaUnique transcriptome patterns of the white and grey matter corroborate structural and functional heterogeneity in the human frontal lobeGene set enrichment analysis of RNA-Seq data: integrating differential expression and splicingOntogeny of small RNA in the regulation of mammalian brain development.The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.Alteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure.Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.The importance of study design for detecting differentially abundant features in high-throughput experiments.Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder.Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illnessCharacterization and Expression of the Zebrafish qki Paralogs.Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brainEpigenetic profiling of human brain differential DNA methylation networks in schizophrenia.Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.Immune system disturbances in schizophrenia.Genes, behavior and next-generation RNA sequencing.Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.Bioinformatic analyses and conceptual synthesis of evidence linking ZNF804A to risk for schizophrenia and bipolar disorder.RNA-seq analysis of amygdala tissue reveals characteristic expression profiles in schizophrenia.RNA sequencing in post-mortem human brains of neuropsychiatric disorders.A review of the role of synaptosomal-associated protein 25 (SNAP-25) in neurological disorders.Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing.Clozapine as a Model for Antipsychotic Development.Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders.Development-related alternative splicing of PAC1 receptor: a key player in schizophrenia?Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.The contribution of alternative splicing to genetic risk for psychiatric disorders.A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen.Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia.Expression of alternatively spliced variants of the Dclk1 gene is regulated by psychotropic drugsINFERNO: inferring the molecular mechanisms of noncoding genetic variantsThe Long Noncoding RNA Landscape in Amygdala Tissues from Schizophrenia Patients
P2860
Q26824947-1F104DD4-57E9-4608-B7F9-93F211ACB0FFQ26996831-D97B5E81-058F-4DE6-A7B3-460A52EEC46DQ28534652-E55F1EEC-91C7-4214-9369-DF4C9F2068D8Q30640271-B5ED1F5C-3C27-4731-8673-527D6AF1D9BBQ34227170-4BE7E902-2EFD-4A3F-AC21-0587D71A3F3EQ34341876-D8A6CA19-ED44-4F4C-924D-0068B15D397AQ34370550-8CB387A1-B390-496F-ABD8-924752229EAAQ34531769-CDA50EF2-2C09-4DE9-8301-EFC227FAD8FCQ34617202-39C23B9F-0F3D-4EE1-AFB2-25D70A3022E7Q34913157-71B69B83-E46D-48B1-8185-317C65F7014DQ35069476-C63BF751-E098-4118-98B8-7628930E77D0Q35110815-0547120D-1F86-4253-8233-0324E8EF6419Q35884081-15F1C711-865A-44DC-9B23-C7479DEB32CDQ36043305-F231BBBA-0AD3-46B3-894D-DA8E783FC583Q36258528-5A3BFDBD-8FF4-4AFB-80EB-936B4B912A9DQ37058606-1F5FF986-8597-4189-90A5-0F76EE50B3F4Q37344544-33FCF8F6-1890-4ACC-9F91-B2A10E132B65Q38063580-7811DDFA-3582-4157-B216-1E6E6318EA74Q38177257-E61DC37B-186C-4943-885F-A8ACAE952067Q38293348-089D345D-8788-49C5-9FDA-0A801CDEA067Q38429862-D9B3360D-AFC4-404E-B62E-169781EB1D10Q38694565-C8C44BBE-0A67-47B5-98FE-7DDD3A3C65E5Q38979399-2797C499-6422-40A7-9342-0AAC82272ECDQ39145696-02E01737-6ECA-49B2-9F2B-00C8E3A38801Q39400094-5EDD8CE5-FBCB-4366-AEF7-6DFE2455EC82Q41291393-FA78E0E4-0F54-4C91-900F-6412E17343B8Q42549730-80209C78-DA25-4386-B601-6A744909AC90Q43868487-B398F8D3-9046-4534-808F-64B52513D18DQ47593150-FCE37C7C-8CBC-4A7F-B4C1-0E8AEC5BBEBCQ47782721-E7D5D6E0-5A08-45FD-8A1C-1760AB90858CQ48040604-EC5829C7-B7A2-4C9F-81D5-47B3252066D8Q52320951-B46F4994-136B-4A25-A9FB-2DC4A0B55E67Q58748155-5D52A0AE-7F60-4A2D-84B9-EBB3C85C237CQ58800816-5BB264A5-439D-4FE2-9056-0B3CE71BCEB3Q58805095-70328AFD-C190-4AD7-BB41-46CEA2AE9CC2
P2860
Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Transcriptome sequencing revea ...... and splicing in schizophrenia.
@ast
Transcriptome sequencing revea ...... and splicing in schizophrenia.
@en
type
label
Transcriptome sequencing revea ...... and splicing in schizophrenia.
@ast
Transcriptome sequencing revea ...... and splicing in schizophrenia.
@en
prefLabel
Transcriptome sequencing revea ...... and splicing in schizophrenia.
@ast
Transcriptome sequencing revea ...... and splicing in schizophrenia.
@en
P2093
P2860
P50
P921
P1433
P1476
Transcriptome sequencing revea ...... and splicing in schizophrenia
@en
P2093
Natalie J Beveridge
Paul A Tooney
Rodney J Scott
Vaughan J Carr
P2860
P304
P356
10.1371/JOURNAL.PONE.0036351
P407
P577
2012-04-27T00:00:00Z